Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

The Carlyle Group Inc. - Common Stock (NQ:CG)

47.00 -0.05 (-0.11%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 15, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 5,258,174
Open 46.48
Bid (Size) 46.11 (1)
Ask (Size) 47.50 (1)
Prev. Close 47.05
Today's Range 45.90 - 47.02
52wk Range 33.02 - 57.50
Shares Outstanding 354,462,148
Dividend Yield 2.98%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Carlyle CEO Harvey Schwartz Says 'Stay Buckled' Amid Market Turmoil – 'It's Just A Question Of Whether The Airbags Come Out
Via Benzinga
Carlyle, SK Capital Partners and bluebird bio Amend Merger Agreement
From bluebird bio, Inc.
Via Business Wire

Performance

YTD
-7.4%
-7.4%
1 Month
+27.1%
+27.1%
3 Month
-7.9%
-7.9%
6 Month
-8.0%
-8.0%
1 Year
+6.7%
+6.7%

More News

Read More
Price Over Earnings Overview: Carlyle Group
Via Benzinga
Acentra Health Supports Utah in Securing CMS Certification for Medicaid Enterprise System Modernization
From Acentra Health
Via GlobeNewswire
Earnings Scheduled For May 8, 2025
Via Benzinga
Earnings Scheduled For May 6, 2025
Via Benzinga
Wall Street Mixed Ahead Of Fed Meeting, Alphabet Sinks: What's Driving Markets Wednesday?
Via Benzinga
Topics Economy
Exposures Interest Rates
What's Driving the Market Sentiment Around Carlyle Group?
Via Benzinga
Earnings Scheduled For February 20, 2025
Via Benzinga
The Analyst Verdict: Carlyle Group In The Eyes Of 6 Experts
Via Benzinga
Carlyle and SK Capital Receive All Required Regulatory Approvals to Complete the Acquisition of bluebird bio
From bluebird bio, Inc.
Via Business Wire
Acentra Health Awarded $27.5 Million Contract from California Medicaid to Continue Providing Preadmission Screening and Resident Review (PASRR) Services
From Acentra Health
Via GlobeNewswire
Bill Miller's Q4 Additions Struggle Amid Market Uncertainty, What Else Is Dragging Them Down?
Via Benzinga
Socially Determined and Acentra Health Partner to Advance Whole Person, Whole Population Healthcare through Enhanced Analytics
From Acentra Health
Via GlobeNewswire
Is Carlyle Group Gaining or Losing Market Support?
Via Benzinga
SoftBank Buys Silicon Valley Firm As It Goes All-In On AI
Via Talk Markets
Topics Artificial Intelligence Stocks / Equities
Exposures Artificial Intelligence
Masayoshi Son's SoftBank Buys Oracle-Backed Ampere For $6.5 Billion To Boost US AI Push
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
Oppenheimer Analysts Slash Estimates For Goldman Sachs, Jefferies Amid Subdued M&A Activity
Via Benzinga
Tariffs Tangle Markets, Businesses, Investors
Via The Motley Fool
Bristol Myers Squibb Scoops Up Its Blood Cancer Drug Partner 2seventy Bio In $286 Million Deal
Via Benzinga
What's Going On With Gene Therapy Company Bluebird Bio Stock Today?
Via Benzinga
bluebird bio Announces Definitive Agreement to be Acquired by Carlyle and SK Capital
From bluebird bio, Inc.
Via Business Wire
US Stocks Dip As Powell Stays Cautious, Intel Climbs, Tesla Sinks To 11-Week Low: What's Driving Markets Tuesday?
Via Benzinga
Carlyle Group Stock Slips After Q4 Profit Miss: Retail Remains Neutral
Via Stocktwits
Acentra Health Welcomes Distinguished Public Sector Health Leaders Calder Lynch and Jami Snyder to its Healthcare Advisory Board; Appoints Julie Boughn as New Chair
From Acentra Health
Via GlobeNewswire

Frequently Asked Questions

Is The Carlyle Group Inc. - Common Stock publicly traded?
Yes, The Carlyle Group Inc. - Common Stock is publicly traded.
What exchange does The Carlyle Group Inc. - Common Stock trade on?
The Carlyle Group Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for The Carlyle Group Inc. - Common Stock?
The ticker symbol for The Carlyle Group Inc. - Common Stock is CG on the Nasdaq Stock Market
What is the current price of The Carlyle Group Inc. - Common Stock?
The current price of The Carlyle Group Inc. - Common Stock is 47.00
When was The Carlyle Group Inc. - Common Stock last traded?
The last trade of The Carlyle Group Inc. - Common Stock was at 05/15/25 04:00 PM ET
What is the market capitalization of The Carlyle Group Inc. - Common Stock?
The market capitalization of The Carlyle Group Inc. - Common Stock is 16.66B
How many shares of The Carlyle Group Inc. - Common Stock are outstanding?
The Carlyle Group Inc. - Common Stock has 17B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.